Dental stem cells: dentinogenic, osteogenic, and neurogenic differentiation and its clinical cell based therapies

Each year approximately $400 billion is spent treating Americans suffering some type of tissue loss or end-stage organ failure. This includes millions of dental and oral craniofacial procedure, ranging from tooth restorations to major reconstruction of facial soft and mineralized tissue. Recently, a...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of dental research : official publication of Indian Society for Dental Research Vol. 23; no. 3; p. 393
Main Authors Brar, Gurlal Singh, Toor, Ravi Sher Singh
Format Journal Article
LanguageEnglish
Published India 01.05.2012
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Each year approximately $400 billion is spent treating Americans suffering some type of tissue loss or end-stage organ failure. This includes millions of dental and oral craniofacial procedure, ranging from tooth restorations to major reconstruction of facial soft and mineralized tissue. Recently, a population of putative post-natal stem cells in human dental pulp (DPSCs) has been identified within the "cell- rich zone" of dental pulp. The other type of stem cells from human exfoliated deciduous teeth (SHED) was identified to be a population of highly proliferative, clonogenic cells. Dental Pulp Stem Cells (DPSCs) can not only be derived from a very accessible tissue resource like SHED but are also capable of providing enough cells for potential cell-based therapies.
ISSN:1998-3603